Pure Red Cell Aplasia
Also known as: Red-Cell Aplasia, Pure / Aplasia, pure red cell / Pure red cell aplasia (PRCA) / Aplasia pure red cell / Red cell aplasia / Pure red cell aplasia (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00443 | Betamethasone | A systemic corticosteroid used to relieve inflammation in various conditions, including but not limited to allergic states, dermatologic disorders, gastrointestinal diseases, and hematological disorders. |
| DB00297 | Bupivacaine | A local anesthetic used in a wide variety of superficial and invasive procedures. |
| DB14545 | Hydrocortisone succinate | A corticosteroid used to treat severe allergic reactions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematological disorders, neoplastic diseases, nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders. |
| DB00959 | Methylprednisolone | A corticosteroid used to treat inflammation or immune reactions across a variety of organ systems, endocrine conditions, and neoplastic diseases. |
| DB14644 | Methylprednisolone hemisuccinate | A water soluble corticosteroid used to treat severe allergic reactions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematological disorders, neoplastic diseases, nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders. |
| DB00860 | Prednisolone | A glucocorticoid used to treat adrenocortical insufficiency, inflammatory conditions, and some cancers. |
| DB00635 | Prednisone | A corticosteroid used to treat inflammation or immune-mediated reactions and to treat endocrine or neoplastic diseases. |
| DB00620 | Triamcinolone | A glucocorticoid used to treat a wide variety of inflammatory conditions of organ systems and tissues. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00149 | Leucine | 1 / 2 | Completed | 1 |
| DB00831 | Trifluoperazine | 1 / 2 | Terminated | 1 |
| DB00087 | Alemtuzumab | 2 | Completed | 1 |
| DB00087 | Alemtuzumab | 2 | Recruiting | 1 |
| DB00111 | Daclizumab | 2 | Terminated | 1 |
| DB08894 | Peginesatide | 2 | Completed | 1 |
| DB00073 | Rituximab | 2 | Completed | 1 |
| DB00877 | Sirolimus | 2 | Recruiting | 1 |
| DB00877 | Sirolimus | 4 | Completed | 1 |
| DB00864 | Tacrolimus | 4 | Unknown Status | 2 |
| DB01008 | Busulfan | Not Available | Completed | 1 |
| DB00531 | Cyclophosphamide | Not Available | Completed | 1 |
| DB00531 | Cyclophosphamide | Not Available | Unknown Status | 1 |
| DB00091 | Cyclosporine | Not Available | Unknown Status | 1 |
| DB00016 | Erythropoietin | Not Available | Completed | 1 |
| DB00099 | Filgrastim | Not Available | Unknown Status | 1 |
| DB00959 | Methylprednisolone | Not Available | Unknown Status | 1 |
| DB00635 | Prednisone | Not Available | Unknown Status | 1 |